Ulia Pharma is an Italian SME providing new technology for flexible dosage forms production. The processes and materials used in traditional pharmaceutical manufacturing are reconverted to produce new innovative drugs.
ULIA PHARMA TECHNOLOGY
UP technology is the simplest solution for the production of oral drugs with flexible dosages and controlled drug release speed: consisting of a single motor and a nozzle, the UP machinery has the minimum number of components useful to produce a customized pill, therefore make decentralized and cost-effective oral drug production possible.
The manufacturing process, protected by an international patent application, consists in covering the inert edible base of the pill with the required amount of drug. The inert base, put in rotation on its own axis of symmetry, is hit by one or more jets of active material and excipients, in order to generate a multi-layered structure as required by the pharmaceutical form.
EUROPEAN PATENT OFFICE WRITTEN OPINION
Ulia Pharma technology
“…provide an apparatus for the automated production of customizable dosage forms in the more quick and reliable manner”
ULIA PHARMA Rendering
ULIA PHARMA Laboratory Test
ULIA PHARMA PARTNERS
ULIA PHARMA PATENTS
EU PATENT IS COMING
All amendments requested by the European Patent Office has been fully accepted: the European patent is expected to be granted in 2021.
Patent Extended in US/EU
Patent application passes to national stages: Europe and United States of America, the world’s leading pharmaceutical markets, are selected.
Granted in Italy
Ulia Pharma’s innovation has been recognized; the Italian patent is granted.
The European Patent Office states the novelty, inventive step and industrial applicability of 16 of UP’s 18 claims.
Ulia Pharma’s first machinery, process and oral forms project is disclosed.
ULIA PHARMA AWARDS
AMable Horizon 2020
Start Cup Lombardy Region (Italy) 2019
Premio Alamo 2018
PIN CUP Puglia Region Italy 2018